RemeGen Co. Ltd. Class A
688331
Rangering i aksjer
#2497
RemeGen Co., Ltd., a biopharmaceutical company, discovers, develops, produces,... RemeGen Co., Ltd., a biopharmaceutical company, discovers, develops, produces, and commercializes biological drugs for the treatment of autoimmune, oncology, and ophthalmic diseases in Mainland China and the United States. The company offers Telitacicept (RC18) for the treatment of systemic lupus erythematosus (SLE) autoimmune disease, rheumatoid arthritis, and myasthenia gravis; and Disitamab Vedotin (RC48), an antibody drug conjugate for the treatment of gastric cancer, urothelial carcinoma, breast cancer, and other tumors. It also develops products in various stages, including RC-28E, a fusion protein that targets vascular endothelial growth factor (VEGF) and fibroblast growth factor (FGF); RC88, an antibody-drug conjugate (ADC) that targets mesothelin; and RC148, a bispecific antibody ADC drug that in Phase1/2 clinical studies targeting program cell death protein 1 (PD-1) and VEGF; RC278, an ADC drug for the treatment of multiple solid tumors; and RC288, a dual-antibody ADC drug for the treatment of various tumors. The company was founded in 2008 and is headquartered in Yantai, the People's Republic of China.
Aksjekurs
$13.90
Markedsverdi
$7.78B
Endring (1 dag)
-4.10%
Endring (1 år)
1.71%
Land
CN
Handel RemeGen Co. Ltd. Class A (688331)
Kategori
Healthcare
Driftsmargin for RemeGen Co. Ltd. Class A (688331)
Driftsmargin per October 2026 TTM: 61.01%
Ifølge RemeGen Co. Ltd. Class A sine siste økonomiske rapporter og aksjekurs er selskapets nåværende driftsmargin (TTM) 61.01%. Ved slutten av 2023 hadde selskapet en driftsmargin på -138.65%.
Historikk for driftsmargin for RemeGen Co. Ltd. Class A fra 2018 til 2026
Driftsmargin ved slutten av hvert år
| År | Driftsmargin | Endre |
|---|---|---|
| 2026 (TTM) | 61.01% | -171.95% |
| 2024 | -84.79% | -38.85% |
| 2023 | -138.65% | 7.56% |
| 2022 | -128.90% | -1,226.75% |
| 2021 | 11.44% | -99.99% |
| 2020 | 145,701.26% | 0.00% |
| 2019 | 0.00% | -100.00% |
| 2018 | -2,147.99% | 0.00% |
Driftsmargin for lignende selskaper eller konkurrenter
| Selskap | Driftsmargin | Forskjell i driftsmargin | Land |
|---|---|---|---|
| 38.59% | -99.37% |
US
|
|
| -149.01% | -102.44% |
US
|
|
| 25.57% | -99.58% |
AU
|
|
| 0.00% | - |
CH
|
|
| 28.81% | -99.53% |
NL
|
Hva er selskapets Driftsmargin?
Driftsmargin er en nøkkelindikator for å vurdere lønnsomheten til et selskap. Høyere Driftsmargins er vanligvis bedre, da de viser at selskapet kan selge sine produkter eller tjenester for mye mer enn produksjonskostnadene. Driftsmargin beregnes ved å dele selskapets inntjening med inntektene.